SCHEMBL21272804

SCHEMBL21272804

O=c1[nH]cnc2c1cc(Cl)n2-c1cccc(Br)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.43
CHEK1 O14757 1/20 0.43
AKT1 P31749 1/20 0.43
FLT3 P36888 1/20 0.43
PIM3 Q86V86 1/20 0.43
USP7 Q93009 1/20 0.43
PARP1 P09874 3/20 0.40
GSK3A P49840 2/20 0.40
GSK3B P49841 2/20 0.40
AURKA O14965 1/20 0.40
DAPK3 O43293 1/20 0.40
JAK2 O60674 1/20 0.40
PRKD3 O94806 1/20 0.40
MAP4K4 O95819 1/20 0.40
PAK4 O96013 1/20 0.40
ABL1 P00519 1/20 0.40
CSF1R P07333 1/20 0.40
RET P07949 1/20 0.40
IGF1R P08069 1/20 0.40
MET P08581 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20971266 0.85 ALDH1A1 (0.50) PIM1PARP1GSK3AGSK3BAURKA
SCHEMBL21273089 0.81 IP6K1 (0.44) PIM1PARP1GSK3AGSK3BAURKA
SCHEMBL21273055 0.80 PARP1 (0.39) PIM1CHEK1AKT1FLT3PIM3
SCHEMBL21273091 0.80 PARP1 (0.49) PIM1PIM3PARP1GSK3AGSK3B
SCHEMBL21272834 0.77 PARP1 (0.47) PIM1PARP1GSK3AGSK3BAURKA
SCHEMBL17868975 0.76 PIM1 (0.46) PIM1CHEK1AKT1FLT3PIM3
SCHEMBL21273198 0.76 USP7 (0.42) USP7GSK3AGSK3BMAT2APDE4A
SCHEMBL21273155 0.75 CYP2C9 (0.46) USP7KMT2AALDH1A1MAPTLMNA
SCHEMBL21273095 0.74 ALDH1A1 (0.50) PIM1CHEK1AKT1FLT3PIM3
SCHEMBL21272838 0.73 IP6K1 (0.46) PIM1PARP1GSK3AGSK3BAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4026832-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 Almac Discovery Limited (GB) 2022-07-13 EP disclosed
US-10766903-B2 Piperidine derivatives as inhibitors of ubiquitin specific protease 7 ALMAC DISCOVERY LIMITED (GB) 2020-09-08 US disclosed
US-20190256518-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 GENETECH, INC. 2019-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190256518-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 USP7, USP5, UBA7 PIM1 1504/4885CHEK1 2417/4885AKT1 3805/4885
US-10766903-B2 Piperidine derivatives as inhibitors of ubiquitin specific protease 7 USP7, USP5, UBA7 PIM1 1504/4885CHEK1 2417/4885AKT1 3805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.